Novo Nordisk

Markets

Novo Nordisk keeps growing, fuelling hopes of a stock rebound

Novo Nordisk reported 18% sales growth in the first half of 2025, despite a profit warning that triggered a record share drop. Goldman Sachs says the sell-off is overdone and analysts highlight a potential buying opportunity.

06/08/2025

Markets

Novo Nordisk shares plummet over 20% on weight-loss drug sale slump

The firm also named Maziar Mike Doustdar as its new CEO on Tuesday, after a gloomy financial forecast spooked investors.

29/07/2025

Healthcare

Why Spain thinks Novo Nordisk may be illegally advertising Ozempic

Spain is investigating Novo Nordisk over concerns it may be indirectly marketing its weight loss drugs. Euronews Health spoke to the country’s health secretary to find out more.

27/06/2025

Health news

Novo Nordisk CEO steps down amid competition for weight loss drugs

Lars Fruergaard Jørgensen, who has led the pharmaceutical giant since 2017, joined the firm in 1991.

16/05/2025

Business

Novo Nordisk cuts forecast as weight-loss drug competition heats up

Novo Nordisk shares jumped following stronger-than-expected first-quarter earnings, despite the company lowering its growth outlook for 2025 amid intensifying competition in the weight-loss drug markets.

07/05/2025

Healthcare

Weight-loss drugs could treat patients with serious liver condition

There are currently no drugs approved in the European Union to treat the liver condition known as MASH, but a new trial of semaglutide has shown “exciting” results.

01/05/2025

Business

New tariffs from the US are about to hit the pharmaceutical sector

Despite sparking global-market turmoil with last week’s announcement, the US President is promising new tariffs, now targeting the previously exempted pharmaceutical sector.

09/04/2025

Markets

Novo Nordisk shares post the biggest monthly decline since 2002

Novo Nordisk’s stocks experienced the sharpest monthly decline since July 2002 due to growing competition and several disappointing trial results. However, analysts remain optimistic about the shares, forecasting a potential price upside of up to 60% over the next 12 months.

01/04/2025

Business

SAP overtook Novo Nordisk to become Europe's most valuable company

The German software company's share price gained 40% in the past year, while Danish drugmaker Novo Nordisk has gradually lost almost half of its own since last summer.

24/03/2025

Markets

Novo Nordisk shares jump after Wegovy price cuts announced

Novo Nordisk announced launching a direct-to-patient online pharmacy NovoCare, offering a more than half-price cut for its weight-loss treatment Wegovy.

06/03/2025

Health news

Obesity drugs could help curb alcohol cravings, study suggests

The new findings add to growing evidence that the medicines could help people with alcohol addiction.

13/02/2025

Business

Novo Nordisk shares surge as weight loss treatments boost profits

Demand for weight-loss drugs surged throughout 2024, outpacing supply for most of the year. In December, Novo Holdings, an investment foundation of Novo Nordisk, acquired three manufacturing sites in Catalent to expand its production capacity.

05/02/2025

Health news

Scientists unveil benefits and risks of blockbuster weight-loss drugs

While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health outcomes.

20/01/2025

Business

Novo Nordisk shares plunge on the back of disappointing trial results

Novo Nordisk shares have plunged 20% amid the disappointing trial result of its latest weight-loss drug CagriSema. The fall wiped out €90bn in market valuation on Friday.

23/12/2024

Business

Eli Lilly shares rise as Zepbound weight-loss test shows solid success

Lilly said patients taking Zepbound lost about 20% of their weight on average compared with nearly 14% for Wegovy. The drug maker also said more patients taking Zepbound achieved at least 25% weight loss.

04/12/2024

Health news

Weight loss drugs could help fight chronic kidney disease, study finds

Researchers said the drugs could make a major difference for chronic kidney disease patients by helping to reduce other risk factors.

26/11/2024

Health news

Teens on anti-obesity drugs less likely to consider or attempt suicide

Researchers said the drugs don’t appear to raise the risk of suicidal thoughts or actions for young people but also urged caution in interpreting the results.

14/10/2024

Health news

France to patients: Take weight loss drug Wegovy on your own dime

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.

11/10/2024

Business

Novo Nordisk boss in US grilling over prices for weight-loss drugs

Novo Nordisk has been criticised by US politicians for the high pricing of its popular weight-loss and diabetes drugs. But CEO Lars Fruergaard Jørgensen has defended the company, attributing the elevated prices to "structural issues" within the US healthcare system.

25/09/2024

Business

Weight loss market: Eli Lilly and Novo Nordisk's rivals muscle in

As Eli Lilly and Novo Nordisk continue to dominate the lucrative weight-loss drug market, smaller competitors are gearing up to release their own treatments, aiming to challenge the two industry leaders.

17/09/2024